Peel Hunt restated their add rating on shares of Sabre Insurance Group (LON:SBRE – Get Rating) in a research report released on Tuesday morning, MarketBeat.com reports. Peel Hunt currently has a GBX 130 ($1.58) price objective on the stock.
Sabre Insurance Group Price Performance
SBRE stock opened at GBX 98.80 ($1.20) on Tuesday. Sabre Insurance Group has a 52-week low of GBX 81.90 ($1.00) and a 52-week high of GBX 242.50 ($2.96). The stock’s fifty day simple moving average is GBX 99.47 and its 200-day simple moving average is GBX 99.53. The company has a quick ratio of 0.21, a current ratio of 0.49 and a debt-to-equity ratio of 0.03. The stock has a market capitalization of £247 million, a price-to-earnings ratio of 1,646.67, a price-to-earnings-growth ratio of 4.08 and a beta of 0.26.
Sabre Insurance Group Cuts Dividend
The company also recently announced a dividend, which will be paid on Thursday, June 1st. Investors of record on Thursday, April 20th will be issued a GBX 1.70 ($0.02) dividend. This represents a yield of 1.76%. The ex-dividend date is Thursday, April 20th. Sabre Insurance Group’s payout ratio is currently 11,666.67%.
Sabre Insurance Group Company Profile
Sabre Insurance Group plc, through its subsidiaries, engages in the writing of general insurance for motor vehicles and motorcycles in the United Kingdom. It offers its products through a network of insurance brokers, as well as through its own direct brands, including Go Girl, Insure 2 Drive, and Drive Smart.
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Sabre Insurance Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabre Insurance Group and related companies with MarketBeat.com's FREE daily email newsletter.